| Medius AG - FLUAD, Injektionssuspension | | 58317 | | 11 | | FLUAD | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 16.08.2017 | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) mind.15 µg et neuraminidasum inactivatum (Virus-Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singapore/GP1908/2015), haemagglutininum influenzae A (H3N2) mind.15 µg et neuraminidasum inactivatum (Virus-Stamm A/Hong Kong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B), haemagglutininum influenzae B mind.15 µg et neuraminidasum inactivatum (Virus-Stamm B/Brisbane/60/2008), adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injektionssuspension | | | | | | Wirkstoffe |
|---|
| .15 Μg et Neuraminidasum Inactivatum (Virus-Stamm A/michigan/45/2015 (H1N1)-Like: Reassortant Virus Ivr-180 Derived from A/singapore/gp1908/2015) | | Haemagglutininum Influenzae a (H1N1) Mind | | Haemagglutininum Influenzae a (H3N2) Mind | | Haemagglutininum Influenzae b mind.15 Μg et Neuraminidasum Inactivatum (Virus-Stamm B/brisbane/60/2008) |
| | | | Hilfsstoffe | | Zusätzliche Information |
|---|
| .15 Μg et Neuraminidasum Inactivatum (Virus-Stamm A/hong Kong/4801/2014 (H3N2)-Like: Reassortant Virus nymc X-263b) | | | | Citratsäure | | | | Calciumchlorid | | | | Dinatrium Phosphat Dihydrat | | | | Kalium Chlorid | | | | Kalium Dihydrogenophosphat | | | | Magnesium Chlorid Hexahydrat | | | | Natrium Chlorid | | excipiens | | Natrii Citras Dihydricus | | | | Polysorbatum 80 | | | | Sorbitani Trioleas | | | | Squalenum | | adjuvans MF59 |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| Es wurden keine Einträge gefunden. |
|
|
